Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Seres Therapeutics, Inc. MCRB

Full chart Compare
Set alert

Price alert · MCRB

All alert types
1.98 USD -0.11 (-5.26%)

At closeNov 6, 2026, 4:06 PM EST

2.01 +0.03 +1.52%

After hours · Nov 6, 4:06 PM ET

1.96 Day range 2.26
1.77 52-week range 28.63
YTD
-86.69%
1 year
-85.71%

Financial health

Altman Z-Score

-24.14 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E 23.3×
FY 2016: -4.3×FY 2017: -4.6×FY 2018: -1.9×FY 2019: -2.8×FY 2020: -21.9×FY 2021: -11.7×FY 2022: -2.4×FY 2023: -1.6×FY 2024: -0.9×FY 2025: 23.3×
FY 2016 5y median -1.6× FY 2025
P/S 167×
FY 2016: 18.1×FY 2017: 12.8×FY 2018: 6.5×FY 2019: 5.7×FY 2020: 58.9×FY 2021: 5.3×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 167×
FY 2016 5y median 0.0× FY 2025
P/B 3.0×
FY 2016: 3.0×FY 2017: 6.8×FY 2018: -3.8×FY 2019: -4.0×FY 2020: 11.2×FY 2021: 5.8×FY 2022: 56.1×FY 2023: -4.0×FY 2024: 9.4×FY 2025: 3.0×
FY 2016 5y median 5.8× FY 2025
P/FCF 152×
FY 2016: 17.6×FY 2017: -5.1×FY 2018: -2.8×FY 2019: -2.5×FY 2020: -20.8×FY 2021: -265×FY 2022: -2.5×FY 2023: -1.4×FY 2024: -0.9×FY 2025: 152×
FY 2016 5y median -1.4× FY 2025
EV/EBITDA 17.2×
FY 2016: -4.0×FY 2017: -4.7×FY 2018: -1.2×FY 2019: -2.8×FY 2020: -23.6×FY 2021: -11.2×FY 2022: -3.5×FY 2023: -1.4×FY 2024: -1.6×FY 2025: 17.2×
FY 2016 5y median -1.6× FY 2025
EV/Sales 214×
FY 2016: 16.1×FY 2017: 11.9×FY 2018: 3.7×FY 2019: 5.1×FY 2020: 56.6×FY 2021: 4.4×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 214×
FY 2016 5y median 0.0× FY 2025
FCF Yield 0.7%
FY 2016: 5.7%FY 2017: -19.6%FY 2018: -35.2%FY 2019: -39.7%FY 2020: -4.8%FY 2021: -0.4%FY 2022: -39.4%FY 2023: -69.9%FY 2024: -115.4%FY 2025: 0.7%
FY 2016 5y median -39.4% FY 2025

Profitability

Gross Margin -423.8%
FY 2016: -276.7%FY 2017: -178.7%FY 2018: -239.5%FY 2019: 100.0%FY 2020: -172.7%FY 2021: 100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -423.8%
FY 2016 5y median 0.0% FY 2025
Operating Margin -11910.1%
FY 2016: -426.5%FY 2017: -284.7%FY 2018: -354.8%FY 2019: -208.3%FY 2020: -265.3%FY 2021: -44.5%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -11910.1%
FY 2016 5y median 0.0% FY 2025
Net Margin 721.9%
FY 2016: -420.7%FY 2017: -278.4%FY 2018: -350.0%FY 2019: -203.7%FY 2020: -268.3%FY 2021: -45.2%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 721.9%
FY 2016 5y median 0.0% FY 2025
ROE 12.9%
FY 2016: -69.0%FY 2017: -147.3%FY 2018: 205.9%FY 2019: 145.4%FY 2020: -51.0%FY 2021: -49.9%FY 2022: -2319.9%FY 2023: 253.5%FY 2024: -1063.3%FY 2025: 12.9%
FY 2016 5y median -49.9% FY 2025
ROIC -72.7%
FY 2016: -38.3%FY 2017: -57.9%FY 2018: -127.9%FY 2019: -79.1%FY 2020: -29.2%FY 2021: -23.1%FY 2022: -67.3%FY 2023: -73.5%FY 2024: -113.1%FY 2025: -72.7%
FY 2016 5y median -72.7% FY 2025
ROA 4.1%
FY 2016: -33.6%FY 2017: -47.2%FY 2018: -82.1%FY 2019: -53.1%FY 2020: -26.0%FY 2021: -18.5%FY 2022: -71.7%FY 2023: -31.7%FY 2024: -104.8%FY 2025: 4.1%
FY 2016 5y median -31.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 47.5%FY 2018: -11.9%FY 2019: 22.1%FY 2020: -3.7%FY 2021: 336.3%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 22.5%
FY 2016: -69.2%FY 2017: 1.6%FY 2018: -9.7%FY 2019: 28.3%FY 2020: -22.6%FY 2021: 26.8%FY 2022: -179.0%FY 2023: -8.4%FY 2024: 37.8%FY 2025: 22.5%
FY 2016 FY 2025
EPS (diluted) 103.4%
FY 2016: 1.3%FY 2017: 3.9%FY 2018: -9.9%FY 2019: 48.9%FY 2020: 10.0%FY 2021: 36.0%FY 2022: -223.7%FY 2023: 61.6%FY 2024: -6.1%FY 2025: 103.4%
FY 2016 FY 2025
Free Cash Flow 100.6%
FY 2016: 149.6%FY 2017: -457.6%FY 2018: 19.2%FY 2019: -19.6%FY 2020: -21.5%FY 2021: 96.9%FY 2022: -8191.8%FY 2023: 47.5%FY 2024: -18.9%FY 2025: 100.6%
FY 2016 FY 2025

Financial Health

Current Ratio 2.6×
FY 2016: 6.5×FY 2017: 4.9×FY 2018: 2.2×FY 2019: 2.2×FY 2020: 5.8×FY 2021: 3.7×FY 2022: 2.3×FY 2023: 1.8×FY 2024: 0.9×FY 2025: 2.6×
FY 2016 5y median 2.3× FY 2025
Quick Ratio 2.6×
FY 2016: 6.5×FY 2017: 4.9×FY 2018: 2.2×FY 2019: 2.2×FY 2020: 5.8×FY 2021: 3.7×FY 2022: 2.3×FY 2023: 1.5×FY 2024: 0.9×FY 2025: 2.6×
FY 2016 5y median 2.3× FY 2025
Debt / Equity 1.9×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: -0.2×FY 2019: -0.9×FY 2020: 0.2×FY 2021: 0.4×FY 2022: 15.1×FY 2023: -4.4×FY 2024: 6.6×FY 2025: 1.9×
FY 2016 5y median 1.9× FY 2025
Net Debt / EBITDA 3.8×
FY 2016: 0.5×FY 2017: 0.3×FY 2018: 0.9×FY 2019: 0.3×FY 2020: 0.9×FY 2021: 2.3×FY 2022: 0.0×FY 2023: -0.4×FY 2024: -0.5×FY 2025: 3.8×
FY 2016 5y median 0.0× FY 2025
Interest Coverage 0.0×
FY 2016: -95.8×FY 2017: -57.5×FY 2018: -85.6×FY 2019: -143×FY 2020: -30.1×FY 2021: -22.2×FY 2022: -29.9×FY 2023: -14.8×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median -14.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31